Adirondack Research & Management Inc. - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 214 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Adirondack Research & Management Inc. ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2021$1,164,000
-22.1%
87,067
+7.8%
1.42%
-19.0%
Q2 2021$1,495,000
-19.1%
80,767
-34.4%
1.75%
-20.0%
Q1 2021$1,849,000
-17.4%
123,148
-20.6%
2.19%
-28.7%
Q4 2020$2,239,000
+28.9%
155,088
-27.3%
3.06%
+26.7%
Q3 2020$1,737,000
+7.4%
213,400
-10.7%
2.42%
+13.9%
Q2 2020$1,617,000
-0.6%
238,900
+3.5%
2.12%
-6.4%
Q1 2020$1,626,000
-55.6%
230,900
-38.1%
2.27%
-28.5%
Q4 2019$3,659,000
-23.2%
372,820
-14.1%
3.17%
-23.8%
Q3 2019$4,764,000
-7.7%
433,920
-2.3%
4.16%
+12.4%
Q2 2019$5,163,000
+14.8%
443,920
-5.8%
3.70%
+32.1%
Q1 2019$4,497,000
-4.2%
471,420
-3.2%
2.80%
-4.5%
Q4 2018$4,694,000
-36.8%
486,920
-6.6%
2.94%
+5.5%
Q3 2018$7,427,000
+18.8%
521,1770.0%2.78%
+14.0%
Q2 2018$6,254,000
-2.8%
521,1770.0%2.44%
-5.5%
Q1 2018$6,437,000
-22.9%
521,177
-9.2%
2.58%
-21.3%
Q4 2017$8,352,000
+2.3%
574,0330.0%3.28%
+2.7%
Q3 2017$8,168,000
+11.5%
574,0330.0%3.19%
+11.9%
Q2 2017$7,325,000
+0.6%
574,0330.0%2.85%
+9.1%
Q1 2017$7,279,000
+28.3%
574,033
+3.3%
2.61%
+35.7%
Q4 2016$5,673,000
+0.5%
555,661
+29.7%
1.93%
-5.4%
Q3 2016$5,644,000
+23.0%
428,561
+18.6%
2.04%
+18.4%
Q2 2016$4,588,000
-3.9%
361,2590.0%1.72%
-0.5%
Q1 2016$4,772,000
-11.1%
361,259
+3.5%
1.73%
-11.0%
Q4 2015$5,369,000
+24.1%
349,0590.0%1.94%
+17.1%
Q3 2015$4,328,000
-9.4%
349,0590.0%1.66%
-5.4%
Q2 2015$4,775,000
+39.9%
349,059
+22.3%
1.75%
+32.4%
Q1 2015$3,414,000
+21.1%
285,459
+29.3%
1.32%
+25.5%
Q4 2014$2,819,000
+4.7%
220,749
+10.0%
1.06%
+5.6%
Q3 2014$2,693,000
-16.4%
200,7490.0%1.00%
-8.3%
Q2 2014$3,222,000
-6.3%
200,749
+5.2%
1.09%
-17.2%
Q1 2014$3,439,000
+16.6%
190,7490.0%1.32%
-8.2%
Q4 2013$2,949,000
+4.0%
190,7490.0%1.43%
-12.3%
Q3 2013$2,836,000
+14.9%
190,7490.0%1.63%
-11.3%
Q2 2013$2,468,000
-4.8%
190,7490.0%1.84%
-13.8%
Q1 2013$2,592,000190,7492.14%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q3 2019
NameSharesValueWeighting ↓
Kent Lake Capital LLC 925,000$12,154,5004.67%
EVR Research LP 1,289,037$16,937,9464.48%
Tamarack Advisers, LP 435,000$5,715,9003.70%
KESTREL INVESTMENT MANAGEMENT CORP 263,900$3,4682.19%
Tamarack Advisers, LP 200,000$2,628,0001.70%
Numerai GP LLC 274,319$3,604,5521.20%
Smith, Graham & Co., Investment Advisors, LP 525,915$6,910,5230.86%
PEREGRINE CAPITAL MANAGEMENT LLC 585,254$7,690,2380.23%
WESTFIELD CAPITAL MANAGEMENT CO LP 2,401,754$31,559,0480.22%
FULLER & THALER ASSET MANAGEMENT, INC. 2,543,242$33,418,1940.19%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders